Hurdles To Patient Engagement: The New Frontier In Drug Development (Part 2)

This is part two of an FDA Week Special Report on patient engagement in the drug development process. Part one focused on the methods FDA and other stakeholders are taking to better engage patients. Part two looks at the regulatory and technological hurdles involved in bringing real-world patient data into the drug development process. The influence of patient-generated data in the drug development process is becoming more apparent as health care stakeholders and even FDA begin to embrace...